Current Affairs in Short: 1 July 2021

An expert panel constituted by the central government has recommended against granting permission to the Serum Institute of India (SII) to conduct Phase II and Phase III clinical trials of the Covavax COVID-19 vaccine on children aged between 2-17 years. CURRENT AFFAIRS